Stocksigma LogoStocksigma Logo

Aspira Pathlab Board Approves Rights Issue Up to Rs 65 Crore

Aspira Pathlab & Diagnostics' Board approved fundraising of up to Rs 65.00 crore via a rights issue of equity shares or convertible instruments to eligible

Aspira Pathlab Board Approves Rights Issue Up to Rs 65 Crore

Aspira Pathlab & Diagnostics Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 10:22 pm

Aspira Pathlab Board Approves Rights Issue Up to Rs 65 Crore Aspira Pathlab & Diagnostics' Board approved fundraising of up to Rs 65.00 crore via a rights issue of equity shares or convertible instruments to eligible shareholders on 12th Sep'26. The issue remains subject to shareholder and regulatory approvals. Additionally, the Board constituted a Rights Issue Committee, chaired by Nikunj Velji Mange, to finalize key terms, including the issue price, entitlement ratio, record date, and appointment of intermediaries.

Original exchange filing (PDF)

More announcements from Aspira Pathlab & Diagnostics Ltd

All Aspira Pathlab & Diagnostics Ltd announcements